Position in AMGN
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$32,897,153
+$1,290,820 QoQ
Shares Held
90,846
+1.1% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#281
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026UNITED CAPITAL FINANCIAL ADVISORS, LLC holds $392,709,829 across 14 Drug Manufacturers - General names. AMGN ranks #5 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
74,694 | $89,590,231 | |
| 2 | JNJ |
Johnson & Johnson
|
345,519 | $87,751,460 | |
| 3 | ABBV |
AbbVie Inc.
|
254,843 | $64,128,692 | |
| 4 | NVO |
Novo Nordisk A S
|
1,000,682 | $47,972,695 | |
| 5 | AMGN |
Amgen Inc
This page
|
90,846 | $32,897,153 | |
| 6 | MRK |
Merck & Co., Inc.
|
142,059 | $18,254,581 | |
| 7 | NVS |
Novartis AG
|
89,770 | $14,068,754 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
108,152 | $13,663,923 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,897,153 | 90,846 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $31,606,333 | 89,829 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $29,719,420 | 90,799 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $23,856,059 | 84,536 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $18,069,075 | 64,715 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $20,005,871 | 64,214 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $15,106,955 | 57,961 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $21,088,644 | 65,450 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $20,605,140 | 65,947 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $12,417,960 | 43,676 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $15,765,062 | 54,736 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $27,265,702 | 101,450 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $23,342,294 | 105,136 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $26,726,913 | 110,556 | Shares | Defined | 2023-08-15 | |
| 2022-12-31 | $34,969,202 | 133,145 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $31,198,064 | 138,412 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $31,207,117 | 128,266 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $32,262,657 | 133,416 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $29,792,552 | 132,429 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $27,811,642 | 130,786 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $31,696,275 | 130,036 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $30,852,440 | 124,000 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $25,556,527 | 111,154 | Shares | Defined | 2021-02-17 | |
| 2020-09-30 | $26,999,416 | 106,230 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $24,245,700 | 102,797 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $44,885,638 | 221,406 | Shares | Defined | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||